Toleranzia AB (OSTO:TOL) ROE % Adjusted to Book Value : -11.56% (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Toleranzia AB ROE % Adjusted to Book Value?

Toleranzia AB's ROE % for the quarter that ended in Dec. 2024 was -10.29%. Toleranzia AB's PB Ratio for the quarter that ended in Dec. 2024 was 0.89. Toleranzia AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -11.56%.

Toleranzia AB ROE % Adjusted to Book Value Historical Data

The historical data trend for Toleranzia AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Toleranzia AB ROE % Adjusted to Book Value Chart

Toleranzia AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-7.80

-6.25

-6.63

-12.56

-5.02

Toleranzia AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-8.98	-2.97	-5.20	-11.38	-11.56

Competitive Comparison of Toleranzia AB's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Toleranzia AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Toleranzia AB's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Toleranzia AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Toleranzia AB's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Toleranzia AB ROE % Adjusted to Book Value Calculation

Toleranzia AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-4.47%	/	0.89
	=	-5.02%

Toleranzia AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-10.29%	/	0.89
	=	-11.56%

Toleranzia AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Toleranzia AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Toleranzia AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Toleranzia AB (OSTO:TOL) » Definitions » ROE % Adjusted to Book Value

Traded in Other Exchanges

N/A

Address

Arvid Wallgrens backe 20, 8th floor, Gothenburg, SWE, SE-413 46

Website

https://www.toleranzia.com

Toleranzia AB is a Swedish biotechnology Company. The company develops drugs that harness the power of the immune system to treat autoimmune orphan diseases The company's drug candidate, TOL2, is being developed for the treatment of the autoimmune neuromuscular disease myasthenia gravis, an orphan disease.